Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided...

Area of Science:

• Microbiology
• Computational Biology
• Drug Discovery

Background:

• Vancomycin-resistant Staphylococcus aureus (VRSA) poses a significant threat due to widespread hospital and community-acquired infections.
• The emergence of multidrug-resistant bacteria necessitates the development of novel therapeutic targets.

Purpose of the Study:

• To identify pathogen-specific drug targets against VRSA using in-silico genome subtraction.
• To discover novel therapeutic compounds effective against VRSA infections.

Main Methods:

• In-silico genome subtraction methodology applied to VRSA proteome.
• Bioinformatic analyses including CD-HIT, BLASTp, KEGG, PSORTb, CELLO v.2.5, ngLOC, SVMprot, and STRING.
• Identification of essential, human non-homologous proteins and analysis of their metabolic pathways and interactions.

Main Results:

• 1987 proteins without human homologues identified from 34,549 VRSA proteins.
• 169 essential S. aureus proteins were identified, with 19 involved in unique metabolic pathways.
• Penicillin-binding protein 1 (pbpA) and hypothetical protein MQW_01796 were identified as top drug target candidates.

Conclusions:

• The identified drug targets hold significant potential for novel drug design against VRSA.
• Further screening of compounds against these targets may lead to effective treatments for Vancomycin-resistant S. aureus infections.